Royal London Asset Management LTD Ironwood Pharmaceuticals Inc Transaction History

Royal London Asset Management LTD

  • $39.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 30, 2019
SELL
$8.27 - $12.73 $1.47 Million - $2.26 Million
-177,210 Closed
0 $0
Q4 2018

Jan 29, 2019
BUY
$7.8 - $16.13 $366,233 - $757,351
46,953 Added 36.05%
177,210 $1.84 Million
Q3 2018

Nov 08, 2018
SELL
$14.31 - $17.65 $126,257 - $155,725
-8,823 Reduced 6.34%
130,257 $0
Q2 2018

Sep 19, 2018
BUY
$11.83 - $16.2 $1.65 Million - $2.25 Million
139,080 New
139,080 $2.66 Million

Others Institutions Holding IRWD

# of Institutions
296
Shares Held
170M
Call Options Held
27.1M
Put Options Held
2.28M
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $953M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email